We are live on ! Find out more
TGI

TRV GP IV Portfolio holdings

AUM $254M
1-Year Est. Return 426.76%
This Fund
S&P 500
This Quarter Est. Return
-13.08%
1 Year Est. Return
+426.76%
3 Year Est. Return
+1,102.13%
5 Year Est. Return
+979.15%
10 Year Est. Return
–
AUM
$206M
AUM Growth
-$39.8M
Cap. Flow
-$1.74M
Cap. Flow %
-0.84%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
TNGX icon
Tango Therapeutics
TNGX
+$1.74M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TNGX icon
1
Tango Therapeutics
TNGX
$3.94B
$152M 73.88%
19,201,475
-162,500
-0.8% -$1.74M
PLRX icon
2
Pliant Therapeutics
PLRX
$66.3M
$31.8M 15.4%
2,132,867
– –
FULC icon
3
Fulcrum Therapeutics
FULC
$289M
$22.1M 10.72%
2,343,154
– –

Similar funds

OPWM
Oxinas Partners Wealth Management Jeffersonville, Indiana $254M AUM 31.6% 1-Year Est. Return
SRCM
Signature Resources Capital Management Newport Beach, California $254M AUM 26.72% 1-Year Est. Return
SOAG
Silver Oak Advisory Group Portland, Oregon $254M AUM 12.01% 1-Year Est. Return
MCM
McKinney Capital Management Houston, Texas $254M AUM
G
Gainplan Bloomfield Hills, Michigan $254M AUM 25.62% 1-Year Est. Return
FFA
Fairfield Financial Advisors Wellesley, Massachusetts $254M AUM 35.88% 1-Year Est. Return
GAM
GEM Asset Management Plymouth, Michigan $254M AUM 23.24% 1-Year Est. Return
AFO
Aurelius Family Office Bedford, New Hampshire $254M AUM 15.09% 1-Year Est. Return

TRV GP IV's Q1 2024 Portfolio in Review

As of Q1 2024, TRV GP IV held 3 positions worth $206M, down 16% from $246M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 0%. TRV GP IV opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • TRV GP IV's biggest Q1 2024 reduction was Tango Therapeutics, cutting an estimated $1.74M.
  • TRV GP IV's ten largest holdings make up 100% of its $206M portfolio in Q1 2024.
  • TRV GP IV opened 0 new positions and closed 0 in Q1 2024.
  • TRV GP IV's portfolio value fell 16% quarter-over-quarter to $206M.

Based on TRV GP IV's 13F filing for Q1 2024, filed 13 May 2024.